Basic Information
SelSym Biotech Develops Novel Therapies to Control Bleeding in Trauma and Surgery. The company provides Hemostatic Healing Hydrogel (H3), enabling healthcare providers to address the current severe shortage of platelet supply and shelf-life limitations, revolutionizing bleeding control in emergency and surgical settings.
Selsym Biotech, Inc.
NorthCarolina,United States of America
less than 15 people
January 01, 2019
info@selsymbio.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios